InvestorsHub Logo

Venture_Cap

06/20/20 12:01 PM

#138432 RE: TenKay #138431

Yep, it’s not a priority for them. It’s a convenient reason to hide the dark side. Based on recent 8ks, they are struggling mightily imo.

The market cap the stock sits at now is $30m ish. That high for a compromised Rotmans. VYST has no other revenue. Time is running out on Covid emergency. Therapeutics are only 3months out.

I’d sell all of RXAIR at highest price possible if they own the IP and find a buyer. I’d give Covid 3months more crisis time. Sell that pos while the iron is hot.